Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Day Care Hospital, Nutritionist.
- Who it may be relevant to
- Registry conditions: Diabetes (DM). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
NUTRI-DIAB: Impact of the Dietitian-Nutritionist Model vs. Day Hospital on the Metabolic Control of Patients With Type 2 Diabetes
Overview
The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.
Interventions
- Other Day Care Hospital
Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital - Other Nutritionist
Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit
Primary outcome measures
- Glycate hemoglobin [Time frame: three months after completion of the intervention]
Eligibility criteria
Inclusion criteria
- Patients with a diagnosis of type 2 diabetes (T2DM) referred to endocrinology due to poor metabolic control.
- Patients on insulin therapy
Exclusion criteria
- Referred from primary care for other reasons such as hypoglycemia.
- Patients with other types of diabetes mellitus or with uncertainty in diagnostic classification.
- Patients on rapid-acting insulin bolus therapy.
- Patients with acute decompensation of diabetes.
- Patients receiving corticosteroid treatment.
- Dependent individuals for activities of daily living (ADL) with a Barthel index score below 60 or with cognitive impairment.
- Language barrier.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Spain · 1 center
- Hospital de Vilafranca — Vilafranca del Penedès
Identifiers
NCT: NCT07285330 · CSAPG-76